Načítá se...
Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
The blood–retinal barrier (BRB) alteration is the hallmark feature of diabetic retinopathy. Vascular endothelial growth factor (VEGF) is a potent vasopermeability factor that has been implicated in the pathogenesis of BRB alteration. Inflammation also plays a crucial role in this process with involv...
Uloženo v:
| Vydáno v: | Indian J Ophthalmol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4821120/ https://ncbi.nlm.nih.gov/pubmed/26953018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0301-4738.178154 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|